PhaseV Israeli Company

PhaseV develops a platform for adaptive clinical trial design and closed-loop execution, leveraging an intuitive user interface and flexible software architecture along with cutting-edge algorithms such as reinforcement learning and causal ML to support key clinical decisions at any point during the trial.